Spots Global Cancer Trial Database for msi
Every month we try and update this database with for msi cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy | NCT06414304 | Colorectal Canc... Colorectal Canc... MSI-H Colorecta... dMMR Colorectal... Cancer Colon Adenocarc... | 18 Years - | OncoAtlas LLC | ||
| Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer | NCT05495776 | Colorectal Canc... Lynch Syndrome Hereditary Colo... MSI | 18 Years - | State Scientific Centre of Coloproctology, Russian Federation | ||
| Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy | NCT06414304 | Colorectal Canc... Colorectal Canc... MSI-H Colorecta... dMMR Colorectal... Cancer Colon Adenocarc... | 18 Years - | OncoAtlas LLC | ||
| Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer | NCT03186326 | Metastatic Colo... MSI | FOLFOX regimen FOLFIRI Protoco... Avelumab Panitumumab Cetuximab Bevacizumab Aflibercept | 18 Years - | Federation Francophone de Cancerologie Digestive | |
| Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors | NCT03596593 | Solid Tumor | SPANOM (identif... | 18 Years - | Peking University | |
| A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of RO7589831 in Participants With Advanced Solid Tumors | NCT06004245 | Advanced Solid ... | RO7589831 | 18 Years - | Hoffmann-La Roche | |
| Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164) | NCT02460198 | Colorectal Carc... | Pembrolizumab | 18 Years - | Merck Sharp & Dohme LLC | |
| Nivolumab and Ipilimumab in Patients With dMMR and/or MSI Metastatic Colorectal Cancer Resistant to Anti-PD1 Monotherapy | NCT05310643 | Metastatic Colo... | Nivolumab Ipilimumab | 18 Years - | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164) | NCT02460198 | Colorectal Carc... | Pembrolizumab | 18 Years - | Merck Sharp & Dohme LLC | |
| Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma | NCT03871959 | Adenocarcinoma ... Adenocarcinoma ... Adenocarcinoma ... | Pembrolizumab DEBIO1143 | 18 Years - | Centre Leon Berard | |
| Relationship of EBV-positive Gastric Cancer and Multiple Genes Associated With Gastric Carcinogenesis | NCT05604378 | Gastric Cancer EBV Infection MSI | Gastrectomy | - | Saint Vincent's Hospital, Korea | |
| Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer | NCT02982694 | MSI ColoRectal Canc... Chemotherapy Resistance, APC | Atezolizumab Bevacizumab | 18 Years - | Vall d'Hebron Institute of Oncology | |
| T Cell Receptor Based Therapy of Metastatic Colorectal Cancer | NCT03431311 | Colorectal Canc... | Adoptive Cell T... | 18 Years - | Oslo University Hospital | |
| Nivolumab and Ipilimumab in Patients With dMMR and/or MSI Metastatic Colorectal Cancer Resistant to Anti-PD1 Monotherapy | NCT05310643 | Metastatic Colo... | Nivolumab Ipilimumab | 18 Years - | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies | NCT03652077 | Cervical Cancer Gastric Cancer Stomach Cancer Gastroesophagea... Esophageal Canc... Hepatocellular ... Melanoma Uveal Melanoma Merkel Cell Car... Mesothelioma MSI Non-small Cell ... NSCLC Ovarian Cancer Squamous Cell C... Small Cell Lung... Renal Cell Carc... RCC Triple-negative... Urothelial Carc... Mismatch Repair... | INCAGN02390 | 18 Years - | Incyte Corporation |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
